| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 4, 2014The HawkOne™ System strengthens Covidien’s directional atherectomy platform with a versatile solution for the treatment of peripheral arterial disease
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 4, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the HawkOne™ directional atherectomy system. The...
-
Nov 4, 2014Results suggest long-term benefits for peripheral artery disease patients treated with directional atherectomy followed by a drug-coated balloon
LAS VEGAS--(BUSINESS WIRE)--Nov. 4, 2014-- Covidien plc (NYSE: COV) today announced 12-month results of the DEFINITIVE AR study, the first randomized study designed to identify the clinical...
-
Nov 2, 2014Expands Spectranetics' portfolio of solutions to treat complex vascular conditions in projected $700 million drug coated balloon segment
COLORADO SPRINGS, Colo., and DUBLIN, Ireland, Nov. 2, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) and Covidien plc (NYSE:COV) today announced a definitive agreement under...
-
Oct 30, 2014- Record 675 HeartWare® Ventricular Assist Systems sold worldwide in Q3
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Oct 28, 2014ReliaTack™ device delivers superior access, stronger fixation and lower cost of care for minimally invasive hernia repair
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 28, 2014-- Covidien plc (NYSE:COV) today announced the launch of ReliaTack™ articulating reloadable fixation device, the first and only of its kind for...